Form 8-K - Current report:
SEC Accession No. 0001104659-25-029642
Filing Date
2025-03-31
Accepted
2025-03-31 08:17:55
Documents
19
Period of Report
2025-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2510892d1_8k.htm   iXBRL 8-K 40258
2 EXHIBIT 2.1 tm2510892d1_ex2-1.htm EX-2.1 649765
3 EXHIBIT 99.1 tm2510892d1_ex99-1.htm EX-99.1 19411
4 EXHIBIT 99.2 tm2510892d1_ex99-2.htm EX-99.2 11720
8 GRAPHIC tm2510892d1_ex99-1img001.jpg GRAPHIC 6265
9 GRAPHIC tm2510892d1_ex99-1img002.jpg GRAPHIC 4325
10 GRAPHIC tm2510892d1_ex99-2img001.jpg GRAPHIC 5922
  Complete submission text file 0001104659-25-029642.txt   1038503

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cyrx-20250331.xsd EX-101.SCH 3015
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyrx-20250331_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyrx-20250331_pre.xml EX-101.PRE 22359
21 EXTRACTED XBRL INSTANCE DOCUMENT tm2510892d1_8k_htm.xml XML 3673
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34632 | Film No.: 25789028
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)